Bronchoscopy Procedures are fastest growing segment fueling the growth of Endobronchial Ultrasound Biopsy Market
![]() |
Endobronchial Ultrasound Biopsy Market |
The global Endobronchial Ultrasound Biopsy Market is estimated to be valued at US$ 722.67 Bn in 2023 and is expected to exhibit a CAGR of 9.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Endobronchial ultrasound is a minimally invasive medical procedure used to examine
the lungs and mediastinum. EBUS biopsy combines bronchoscopy with ultrasound to
guide transbronchial needle aspiration for lung and mediastinal lesions. It has
advantages of real time images and minimally invasive procedure that avoids
surgery.
Market key trends:
One of the key trends in the endobronchial ultrasound biopsy market is the
growing adoption of EBUS-TBNA (transbronchial needle aspiration) for diagnosis
of lung cancer. According to American Cancer Society, lung cancer is the second
most common type of cancer. Early diagnosis is important for improving
outcomes. EBUS-TBNA has emerged as gold standard for diagnosis of lung cancer
and mediastinal lymph nodes staging. It has high diagnostic yield, shorter
procedure time and reduced risk of complications compared to surgery. The
procedure provides real time images for precise needle aspiration of suspicious
lesions under ultrasound guidance via bronchoscope.
Segment Analysis
The global
endobronchial ultrasound biopsy market is segmented based on product type,
application, end-user, and geography. Based on product type, the market is
classified into needles, catheters, bronchoscopes, and ultrasound probes. The
needles segment currently dominates the market owing to its high usage and
demand for minimally invasive diagnostic and therapeutic procedures.
Key Takeaways
The global Endobronchial
Ultrasound Biopsy Market Demand is expected to witness high, exhibiting
CAGR of 9.0% over the forecast period, due to increasing prevalence of lung
cancers and respiratory disorders.
Regional analysis
North America currently dominates the market due to advanced medical
infrastructure and favorable reimbursement policies. Asia Pacific is expected
to grow at the fastest rate during the forecast period due to rising awareness,
improving healthcare expenditure, and increasing incidence of lung cancer in
the region.
Key players
Key players operating in the endobronchial ultrasound biopsy market are
Fujifilm Holdings Corporation, Olympus Corporation, Hitachi Medical
Corporation, Pentax Medical (Hoya Corporation), Boston Scientific Corporation,
Cook Medical, Carl Zeiss Meditec AG, Medtronic plc, BARD Diagnostic Systems,
Inc., and ACON Laboratories, Inc. These players are focusing on new product
launches and strategic collaborations to gain maximum share in the market.
Get more insights on this topic:
Comments
Post a Comment